PM2.5 and hospital admissions among Medicare enrollees with chronic debilitating brain disorders

Maayan Yitshak-Sade1, Rachel Nethery2, Joel D Schwartz3

  • 1Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Abstract

Insights

Short-term exposure to fine particulate matter (PM2.5) significantly increases hospital admissions for Medicare beneficiaries with chronic debilitating brain disorders (CDBD). Individuals with Parkinson

Area of Science:

  • Environmental Health
  • Neurology
  • Public Health

Background:

  • Long-term fine particulate matter (PM2.5) exposure is linked to chronic brain disorders.
  • The impact of short-term PM2.5 exposure on healthcare demand for Medicare enrollees with chronic debilitating brain disorders (CDBD) is understudied.
  • This study investigates the association between acute PM2.5 exposure and hospital admissions in individuals with Parkinson's disease (PD) and Alzheimer's disease (AD)/dementia.

Purpose of the Study:

  • To assess the effect of short-term high PM2.5 exposure on all-cause and cause-specific hospital admissions.
  • To evaluate the increased susceptibility of Medicare enrollees with CDBD to PM2.5-related health conditions.

Main Methods:

  • Utilized a causal modeling approach with Medicare beneficiary data (2000-2014).
  • Employed propensity score matching to compare high-pollution (PM2.5 > 17.4 μg/m³) and low-pollution zip code-days.
  • Estimated the percentage change in hospital admissions attributable to high PM2.5 exposure.

Main Results:

  • Significant increases in all-cause hospital admissions observed: 2.53% for PD and 2.49% for AD/dementia.
  • Pneumonia and urinary tract infections showed the largest increases among common causes.
  • Effects were more pronounced in the CDBD population compared to the general Medicare population, even at EPA-deemed safe PM2.5 levels.

Conclusions:

  • Medicare beneficiaries with CDBD face a higher risk of hospitalization following acute exposure to PM2.5.
  • This risk exists even at PM2.5 concentrations below the EPA's National Ambient Air Quality Standards.
  • Highlights the vulnerability of individuals with brain disorders to air pollution.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
573
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.9K